EP1733056
METHOD TO DETERMINE RESPONSIVENESS OF CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING TREATMENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.3.2005EP published:
22.5.2013EP application number:
05757467.5
EPO information:
European Patent Register
Max expiry date:
30.3.2025
Title:
METHOD TO DETERMINE RESPONSIVENESS OF CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING TREATMENTS
Timeline
Today
31.3.2005EP application
22.5.2013EP Publication
Owner
Name:
THE GENERAL HOSPITAL CORPORATIONAddress:
55 Fruit Street, 02114, Boston, MA, US
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Inventor
Name:
BELL, Daphne WinifredAddress:
Chevy Chase, MD, US
Name:
HABER, Daniel, A.Address:
Chestnut Hill, MA, US
Name:
JANNE, Pasi, AnteroAddress:
Newton, MA, US
Name:
JOHNSON, Bruce, E.Address:
Brookline, MA, US
Name:
LYNCH, Thomas, J.Address:
Newton, MA, US
Name:
MEYERSON, MatthewAddress:
Concord, MA, US
Name:
PAEZ, Juan, GuillermoAddress:
Boston, MA, US
Name:
SELLERS, William, R.Address:
Brookline, MA, US
Name:
SETTLEMAN, Jeffrey, E.Address:
Newton, MA, US
Name:
SORDELLA, RaffaellaAddress:
Syosset, NY, US
Priority
Number:
558218 PDate:
31.3.2004Country:
US
Number:
561095 PDate:
9.4.2004Country:
US
Number:
565753 PDate:
27.4.2004Country:
US
Number:
565985 PDate:
27.4.2004Country:
US
Number:
574035 PDate:
25.5.2004Country:
US
Number:
577916 PDate:
7.6.2004Country:
US
Number:
592287 PDate:
29.7.2004Country:
US
Classification
Categories:
C12Q 1/68, C07H 21/04